Y-Intercept (HK)’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,016	Closed	-$112K	–	1842
2024 Q1	$112K	Buy	+24,016	New	+$112K	0.01%	1268
2023 Q3	–	Sell	-42,574	Closed	-$105K	–	1508
2023 Q2	$105K	Buy	+42,574	New	+$105K	0.01%	1088